Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25948768 | 0.98 | FDPS (0.32) | FDPSKMT2A | |
| SCHEMBL25948776 | 0.93 | — | — | |
| SCHEMBL13734124 | 0.85 | — | — | |
| SCHEMBL19815506 | 0.76 | LMNA (0.39) | FDPSKMT2A | |
| SCHEMBL27377753 | 0.76 | FDPS (0.34) | FDPSKMT2A | |
| SCHEMBL25873251 | 0.74 | LMNA (0.38) | FDPSKMT2A | |
| SCHEMBL27706076 | 0.71 | SLC6A2 (0.33) | FDPS | |
| SCHEMBL24416130 | 0.71 | FDPS (0.31) | FDPS | |
| SCHEMBL27995429 | 0.70 | APLNR (0.38) | — | |
| SCHEMBL4203277 | 0.70 | PRCP (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102471339-A | Pyrrolopyridine inhibitors of kinases | ABBOTT LAB | 2012-05-23 | — | — | CN | claimed |
| US-20230246229-A1 | ORGANIC SULFONATE ELECTROLYTE ADDITIVES FOR ZINC BATTERIES | Octet Scientific, Inc. | 2023-08-03 | — | — | US | disclosed |
| US-20220144759-A1 | COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2022-05-12 | — | — | US | disclosed |
| CN-102471339-A | Pyrrolopyridine inhibitors of kinases | ABBOTT LAB | 2012-05-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220144759-A1 | COMPOUND | SFXN3, SFXN1, CBR3 | FDPS 1439/4885KMT2A 2384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.